Clinical Trials on Proton Pubm Inhibitor in Korea, Democratic People's Republic of
Total 252 results
-
JW PharmaceuticalRecruitingHemophilia A With Inhibitor | Hemophilia A Without InhibitorKorea, Republic of
-
Samsung Medical CenterSuspendedAromatase (CYP19) Polymorphism Between AI-responsive and AI-resistant Breast Cancer in Korea (CYP19)Polymorphism | CYP19 | Aromatase InhibitorKorea, Republic of
-
Samsung Changwon HospitalUnknownPeptic Ulcer | Peptic Ulcer Hemorrhage | Peptic Ulcer, Acute With Hemorrhage | Proton Pump Inhibitor OverdoseKorea, Republic of
-
Samsung Medical CenterCompletedAdherence, Medication | Percutaneous Coronary Intervention | Compliance, Medication | Platelet Aggregation Inhibitors | Hydroxymethylglutaryl-coa Reductase Inhibitors | Persistence, MedicationKorea, Republic of
-
Asan Medical CenterCompletedGastric Cancer | Histone Deacetylase InhibitorKorea, Republic of
-
Samsung Medical CenterRecruitingTriple Negative Breast Cancer | Immune Checkpoint InhibitorKorea, Republic of
-
Yonsei UniversityCanariaBio Inc.RecruitingPARP Inhibitor Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Not Candidate for Platinum RetreatmentKorea, Republic of
-
Sun U. KwonNot yet recruitingStroke, Acute Ischemic | PCSK9 InhibitorKorea, Republic of
-
Yonsei UniversityRecruitingDiabetes Mellitus | Sodium-Glucose Transporter 2 Inhibitors | Cellular SenescenceKorea, Republic of
-
Samsung Medical CenterRecruitingCarcinoma, Non-Small-Cell Lung | Immune Checkpoint InhibitorsKorea, Republic of
-
Yonsei UniversityChong Kun Dang Pharmaceutical Corp.UnknownCoronary Artery Disease | Coronary Arteriosclerosis | Hydroxymethylglutaryl-CoA Reductase InhibitorsKorea, Republic of
-
Ewha Womans University Mokdong HospitalEnrolling by invitationDiabetes Mellitus, Type 2 | Atrial Fibrillation | SGLT-2 InhibitorKorea, Republic of
-
AryoGen Pharmed Co.CompletedHemophilia A With Inhibitor | Hemophilia B With InhibitorIran, Islamic Republic of
-
Gyeongsang National University HospitalCompletedMyocardial Reperfusion Injury | Platelet Aggregation Inhibitors | Anti-inflammatory AgentKorea, Republic of
-
Samsung Medical CenterUnknownLiver Neoplasm | Proton TherapyKorea, Republic of
-
AryoGen Pharmed Co.CompletedFactor VII Deficiency | Hemophilia A With Inhibitor | Hemophilia B With Inhibitor | Glanzmann's ThrombastheniaIran, Islamic Republic of
-
Kiyuk Chang, MD,PhDRecruitingMyocardial Infarction | Statin Adverse Reaction | HMG-CoA Reductase Inhibitor ToxicityKorea, Republic of
-
Seoul National University HospitalCompletedAgeing | Photo-agingKorea, Republic of
-
Yonsei UniversityTakedaRecruitingPlatinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP InhibitorKorea, Republic of
-
Seoul National University HospitalCompleted
-
Samsung Medical CenterActive, not recruitingNon-Small Cell Lung Cancer With EGFR T790M Mutation | With Brain and/or Leptomeningeal Metastasis | Failed Tyrosine Kinase InhibitorsKorea, Republic of
-
Samsung Medical CenterCompletedLiver Neoplasm | Proton Therapy | Portal Vein Tumor ThrombosisKorea, Republic of
-
Yonsei UniversityNot yet recruiting
-
Changhoon YooCompletedCholangiocarcinoma | Biliary Tract Cancer | HER-2 Gene Amplification | HER-2 Protein OverexpressionKorea, Republic of
-
Korean Multiple Myeloma Working PartyJanssen-Cilag Ltd.UnknownMultiple MyelomaKorea, Republic of
-
Green Cross CorporationDream CIS, Inc.CompletedHemophiliaKorea, Republic of
-
Kyowa Kirin Korea Co., Ltd.TerminatedPhase 1 Portion : Non Small Cell Lung Cancer(NSCLC), Small Cell Lung Cancer(SCLC), Mesothelioma | Phase 2 Portion : Small Cell Lung Cancer(SCLC)Korea, Republic of
-
Seoul National University HospitalRecruitingMultiple MyelomaKorea, Republic of
-
Samsung Medical CenterRecruiting
-
Samsung Medical CenterActive, not recruitingMultiple MyelomaKorea, Republic of
-
Janssen Korea, Ltd., KoreaCompletedMultiple MyelomaKorea, Republic of
-
Korean Multiple Myeloma Working PartyJanssen-Cilag Ltd.CompletedMultiple MyelomaKorea, Republic of
-
Seoul St. Mary's HospitalActive, not recruitingMyeloma MultipleKorea, Republic of
-
Samsung Medical CenterCompletedMultiple MyelomaKorea, Republic of
-
Bristol-Myers SquibbWithdrawnMultiple MyelomaKorea, Republic of
-
Asan Medical CenterUnknownMultiple MyelomaKorea, Republic of
-
Korean Multiple Myeloma Working PartyCelgene CorporationUnknownMultiple MyelomaKorea, Republic of
-
Samsung Medical CenterRecruiting
-
PfizerCompletedHemophilia BKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownMyeloma, MultipleKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedLymphoma | Multiple MyelomaKorea, Republic of
-
Kosin University Gospel HospitalCompletedRelapsed and/or refractorY Multiple MyelomaKorea, Republic of
-
Seoul National University HospitalUnknownPlasmacytoma | Multiple Myeloma in Relapse | DaratumumabKorea, Republic of
-
TiumBio Co., Ltd.RecruitingHemophilia A | Hemophilia B | Blood Coagulation DisordersKorea, Republic of
-
Ulsan University HospitalCompletedMultiple MyelomaKorea, Republic of
-
BayerCompleted
-
Pusan National University HospitalUnknownLymphoma | Multiple Myeloma | Peripheral Neuropathy | Toxicity Due to ChemotherapyKorea, Republic of
-
GI Cell, Inc.RecruitingAdvanced Solid Tumors | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Non-Hodgkin LymphomaKorea, Republic of
-
Cooperative Study Group A for HematologyCompletedLymphoma | Multiple Myeloma | Chronic Lymphocytic LeukemiaKorea, Republic of
-
Kosin University Gospel HospitalCelgeneActive, not recruitingMultiple MyelomaKorea, Republic of